Mutations in SPINT2 encoding the epithelial serine protease inhibitor hepatocyte growth factor activator inhibitor-2 (HAI-2) are associated with congenital tufting enteropathy. However, the functions of HAI-2 in vivo are poorly understood. Here we used tamoxifen-induced Cre-LoxP recombination in mice to ablate Spint2. Mice lacking Spint2 died within 6 days after initiating tamoxifen treatment and showed severe epithelial damage in the whole intestinal tracts, and, to a lesser extent, the extrahepatic bile duct. The intestinal epithelium showed enhanced exfoliation, villous atrophy, enterocyte tufts and elongated crypts. Organoid crypt culture indicated that Spint2 ablation induced Epcam cleavage with decreased claudin-7 levels and resulted in organoid rupture. These organoid changes could be rescued by addition of serine protease inhibitors aprotinin, camostat mesilate and matriptase-selective α-ketobenzothiazole as well as by co-deletion of Prss8, encoding the serine protease prostasin. These results indicate that HAI-2 is an essential cellular inhibitor for maintaining intestinal epithelium architecture.
SPINT2 encodes the type 1 transmembrane protein hepatocyte growth factor activator inhibitor (HAI)-2 that has two extracellular Kunitz-type serine protease inhibitor domains, namely KD1 (N-terminal side Kunitz domain) and KD2 (C-terminal side Kunitz domain), a single path transmembrane domain and a short intracytoplasmic domain1,2. The protease inhibitor domain of HAI-2 is homologous to that of HAI-1. HAI-2 and HAI-1 also have a similar anti-protease spectrum and are frequently co-expressed by epithelial cells. They regulate the activities of serum hepatocyte growth factor activator (HGFA), cellular type 2 transmembrane serine proteases (TTSP), particularly matriptase, and glycosylphosphatidylinositol-anchored serine protease, Prss8 (also known as prostasin)1,3,4,5. However, in a human cell line expressing both HAI-1 and HAI-2, HAI-2 could not compensate for loss of HAI-1 and vice versa, and silencing of SPINT1 or SPINT2 produces specific and differing phenotypes, suggesting that these two protease inhibitors have distinct roles in epithelial cells1,6,7. Indeed, HAI-1 has a distinct cell surface localization, whereas HAI-2 localizes to the cytoplasm8,9,10. In mice, deletion of either Spint1 or Spint2 produces an embryonic lethal phenotype, also indicating that Hai-2 does not compensate for loss of Hai-1 and vice versa in vivo11,12.
Mutations in the SPINT2 gene cause a syndromic form of congenital sodium diarrhea (CSD), a rare autosomal-recessive disorder that occurs during infancy13, suggesting a fundamental role for HAI-2 in the function of intestinal mucosa. Syndromic CSD is associated with choanal or anal atresia, hypertelorism, and corneal erosions. Five distinct mutations of the SPINT2 gene have been reported for syndromic CSD, and the mutations associated with this disease result in either reduced protease inhibitor activity of HAI-2 or loss of HAI-2 synthesis13,14,15. Notably, a single amino acid mutation in KD2 (Y163C) is sufficient to induce syndromic CSD, suggesting that KD2 is critical for HAI-2 function in the intestine. For histopathological classification, SPINT2 mutation-related enteropathy is classified as congenital tufted enteropathy (CTE), characterized by villous atrophy and focal crowding at the villus tips due to disorganization of enterocytes15,16. Given that conventional CTE is caused by mutations in the EPCAM gene that encodes epithelial cell adhesion molecule (EpCAM)15, SPINT2 mutation-induced enteropathy may arise from enhanced EpCAM cleavage induced by dysregulated matriptase due to insufficient HAI-2 function, as suggested in a recent in vitro study by Wu et al.17.
Spint2 knockout mice are embryonic lethal, and show embryonic ectoderm clefting, defects in neural tube closure, and impaired development of the placental labyrinth12. However, there are few reports that analyzed the in vivo molecular functions of HAI-2/Hai-2. Szabo et al.18 showed that crossbreeding Spint2 null mice with Prss8 (also known as prostasin) hypomorphic mutant mice rescued the embryonic lethal phenotype associated with Spint2 deficiency19. Analysis of intestinal epithelium of double mutant neonates indicated that Hai-2 loss results in abnormal localization and activation of matriptase through Prss8 dysregulation4. Those neonates shows histological changes of the intestine reminiscent to CTE and die within 4 to 7 days after birth19. However, the Spint2-Prss8 double mutant mouse model is insufficient for use in studies to clarify the role of Hai-2 in normal homeostasis and disease in vivo when wild-type Prss8 is present. Therefore, a conditional knockout mouse system for Spint2 is required to analyze the in vivo physiological and pathophysiological roles of HAI-2/Hai-2 in detail.
In this report we describe the generation of a conditional Spint2 knockout mouse model based on the Cre recombinase and LoxP system. Using a tamoxifen-inducible Cre recombinase (CreERT2) expression system, we examined the effect of spontaneous Spint2 deletion on mice 6 weeks after birth. We found that Hai-2 is an essential protease inhibitor for epithelial integrity, Epcam homeostasis and mucosal organization of the intestinal tract.
Lethal effect of spontaneous Hai-2 loss in mice
To circumvent the embryonic lethality associated with Hai-2 deficiency, we engineered mice homozygous for Spint2 floxed alleles in which Cre recombinase expression results in the deletion of most of the Spint2 gene coding region, including exons encoding KD1 (exon 2) and KD2 (exon 5) (Fig. 1a and Supplementary Fig. 1a). The floxed mice were then crossed with ROSA26-CreERT2 mice to generate Spint2LoxP/LoxPCreERT2 mice. We then analyzed the effects of Spint2 deletion following intraperitoneal administration of tamoxifen to Spint2LoxP/LoxPCreERT2 mice (homozygous Spint2 deletion) at 6 weeks of age to activate the Cre recombinase and compared the induced phenotypes with those of vehicle-treated controls (wild-type Spint2) and also with tamoxifen-treated Spint2LoxP/+CreERT2 mice (heterozygous Spint2 deletion). Within three days, tamoxifen-treated Spint2LoxP/LoxPCreERT2 mice were lethargic and had significant weight loss (Fig. 1b). Three days after starting tamoxifen treatment, Hai-2 mRNA was hardly detectable in major Hai-2-expressing organs such as the intestinal tract (Fig. 1c). Genomic polymerase chain reaction (PCR) confirmed the DNA rearrangement in all tissues except for the brain (Supplementary Fig. 1b). Notably, the Spint2LoxP/LoxPCreERT2 mice survived no more than 6 days after beginning tamoxifen treatment, indicating that the induced loss of Hai-2 protein had a lethal effect (Fig. 1d). Similar results were seen for another Spint2LoxP/LoxP mouse line derived from an independently targeted embryonic stem (ES) clone (ES89; Supplementary Table 1).
Hai-2 loss induced severe epithelial damage of the intestine
To clarify the cause of lethality in Spint2LoxP/LoxPCreERT2 mice, we sacrificed the mice 24, 36, 48, and 72 h after starting tamoxifen treatment. At 72 h, macroscopic phenotypes were observed in the gastrointestinal tracts of tamoxifen-treated Spint2LoxP/LoxPCreERT2 mice, but not in other organs. In the treated mice, the length of the intestine was shorter compared to the control mice and the tissue showed diffuse mucosal damage. The stomach was expanded (Fig. 2a). Subsequent histopathological evaluation revealed successful ablation of the Hai-2 protein and diffuse epithelial damage with mucosal disorganization throughout the intestinal tracts of Spint2LoxP/LoxPCreERT2 mice. In the small intestine, 72 h after starting the tamoxifen treatment Spint2 inactivation dramatically altered the mucosal architecture as evidenced by severe villus atrophy and significantly elongated crypts that showed proliferative activity (Fig. 2b). The ratio of villous length relative to the corresponding crypt depth was significantly decreased in tamoxifen-treated mice relative to vehicle-treated control mice (p = 0.0005) (Supplementary Fig. 2a). In the villous epithelium, stacking of enterocyte nuclei produced a tufted appearance compatible with descriptions of intestinal specimens from CTE patients (Fig. 2b)15,16. The time-course observation also indicated that the number of enterocytes positive for cleaved caspase-3 increased in the upper portion of the crypts and villus base 36 h after tamoxifen treatment (Supplementary Fig. 2b). After 48 h, increased exfoliation of single epithelial cells was present, with peeling of enterocyte sheets from the villous tip (Fig. 2c). These peeling cells were positive for staining with antibodies against cleaved caspase-3 and single-strand DNA (ssDNA), suggestive of apoptotic changes (Fig. 2c). Meanwhile, the number of Paneth cells decreased in the crypt base (Fig. 2d) in a statistically significant level (p = 0.0028, Student t-test, Supplementary Fig. 2c).
Diffuse epithelial damage was also evident in the large intestine. Both the cecum and colon showed obvious, diffuse epithelial damage 36 h after treatment, with increased numbers of apoptotic bodies and exfoliating cells (Fig. 3a). The number of crypts was decreased by 48 h, followed by an active regeneration phase when elongated crypts became apparent. After 72 h, mucosal disorganization was evident, showing marked mucosal thickening with elongated crypts, reactive epithelial cell atypia, and small tufted structures consisting of stacked enterocytes on the surface (Fig. 3a, b). The elongated crypts were composed mostly of Ki67-positive proliferating cells, and many detached cells having pyknotic nuclei were also present (Fig. 3b). The number of goblet cells showed a time-dependent decrease after tamoxifen treatment (Fig. 3c). Collectively, the absence of Hai-2 proteins impaired the terminal differentiation capacity needed to establish a normal epithelial structure. However, no increase in the frequency of β-catenin nuclear translocation was observed during the observation period, indicating that abnormal Wnt/β-catenin signaling did not contribute to the Hai-2 loss-induced enteropathy (Supplementary Fig. 2d).
Although the glandular epithelium of the stomach also showed slightly increased amounts of apoptosis and focal erosion, these changes were not as pronounced as those seen in the intestine (Supplementary Fig. 3). Thus, the marked stomach distention was likely secondary to intestinal dysfunction. Taken together, the marked structural damages and dysfunction of the intestinal epithelium likely underpin the lethality caused by spontaneous loss of Hai-2 in mice.
Extrahepatic biliary tracts were also affected by Hai-2 loss
As HAI-2/Hai-2 is widely expressed in epithelial tissues in humans and mice1,2,20, we also searched for additional histopathological changes in other epithelial tissues. Significant alterations were observed in the epithelium of the gallbladder and extrahepatic bile duct of Spint2LoxP/LoxPCreERT2 mice. The gallbladder epithelial cells tended to have a hobnail appearance, occasionally forming a slight tufted structure and increased exfoliation (Fig. 4a). However, apoptotic bodies were not evident compared with that seen in the intestinal epithelium. Although the epithelium of the extrahepatic biliary tract showed similar changes, the intrahepatic small bile ducts and pancreatic duct were not notably affected by Hai-2 ablation (Fig. 4b and Supplementary Fig. 3). In accordance with this observation, Hai-2 expression levels were lower in the intrahepatic small bile ducts and pancreatic ducts compared with the epithelia of gallbladder and extrahepatic bile duct (Fig. 4). The skin, bronchopulmonary epithelial cells, esophageal epithelium, and renal tubules showed no obvious histopathological changes during the observation period (Supplementary Fig. 3).
Hai-2 loss led to destruction of intestinal organoids
Epithelial damage and disorganization of the intestinal architecture in Spint2-deleted mice could be a direct effect of Hai-2 loss in epithelial cells or arise from secondary stromal inflammation caused by leaky epithelia and intestinal microbial colonization. To distinguish between these possibilities, we performed in vitro three-dimensional (3-D) crypt organoid culture of Spint2LoxP/LoxPCreERT2 small intestine cells. Similar to in vivo observations, deterioration of organoid integrity began 24–28 h after treatment with 4-hydroxytamoxifen (4-OHT) (Fig. 5a and Supplementary Movies 1 and 2). At 36 h (Fig. 5b), destruction or rupture of crypt structure was apparent (Supplementary Movies 1 and 2), whereas the vehicle-treated organoids were intact (Supplementary Movie 3).
Disruption of Epcam/claudin-7 complex by Hai-2 loss
CSD patients, including those with syndromic-form CSD caused by SPINT2 mutation, show intestinal histology compatible with that observed in CTE caused by EPCAM mutations. Therefore, we performed immunohistochemical analysis of the expression and localization of Epcam and one of its essential partners in the intestinal epithelium, claudin-721,22. Hai-2-deficient epithelium showed decreased cell surface Epcam immunoreactivity and mislocalization within the cytoplasm of disorganized epithelial cells, particularly in cells forming tufts, as well as accompanying decreases in claudin-7 immunoreactivity (Fig. 6a). The disruption and mislocalization of Epcam peaked 48 h after tamoxifen treatment, as did increases in mucosal permeability (Fig. 6b, c). Loss of cell surface Epcam and claudin-7 immunoreactivity was also observed in Hai-2-deficient extrahepatic biliary epithelium (Fig. 6d).
We then analyzed Epcam and claudin-7 expression in 3-D intestinal organoid cultures from Spint2LoxP/LoxPCreERT2 mice. Immunoblot analysis showed enhanced levels of a 35-kDa cleavage product of Epcam in the absence of Hai-2 as well as markedly decreased claudin-7 levels (Fig. 7a). Immunofluorescence analysis of these proteins also showed significantly decreased cell surface Epcam and claudin-7 in organoids after 4-OHT treatment (Fig. 7a). On the other hand, Epcam and claudin-7 mRNA levels were not affected (Supplementary Fig. 4), indicating that the decrease in cell surface Epcam and claudin-7 in response to Spint2-deletion occurred at a post-translational level. Importantly, addition of the protease inhibitor aprotinin to the culture media significantly suppressed Epcam cleavage and concomitant decreases in claudin-7 levels (Fig. 7a). Therefore, an excess of trypsin-like serine protease activity was likely responsible for Epcam cleavage. Notably, aprotinin rescued Hai-2 ablation-induced destruction in organoids (Fig. 7b). Similar in vitro results were also obtained following the addition of the synthetic serine protease inhibitor camostat mesilate (Fig. 7c). However, in vivo administration of camostat mesilate (oral or intraperitoneal) could not rescue the lethal phenotype of Spint2LoxP/LoxPCreERT2 mice after tamoxifen treatment (Supplementary Fig. 5). The ineffectiveness of camostat mesilate in vivo may be due to insufficient concentration of the inhibitor in the intestinal microenvironment in vivo, which will require further studies.
There were no significant changes in the expression of other junctional proteins, including E-cadherin, claudin-2 and ZO-1 in response to Hai-2 ablation (Fig. 7d). Taken together, these results indicate that Hai-2 is an essential cellular protease inhibitor needed to stabilize the Epcam/claudin-7 complex in the intestine.
Prss8 was required for Epcam cleavage in Spint2 −/− organoids
In mouse studies, embryonic lethality of Spint2−/− mice could be prevented by reducing Prss8 (prostasin) activity4,18,19. In the human intestinal epithelial cell line Caco2, HAI-2 regulates PRSS8, which is required for normal cell surface localization and function of matriptase4,23. Moreover, in these cells, HAI-2 insufficiency leads to enhanced EpCAM cleavage by matriptase17. These lines of evidence suggest that phenotypes induced by spontaneous ablation of Hai-2 may be secondary to dysregulation of the Prss8-matriptase axis. To explore this possibility, we crossed Spint2LoxP/+CreERT2 mice with Prss8LoxP/+ mice to generate either Spint2LoxP/LoxPPrss8LoxP/+CreERT2, Spint2LoxP/+Prss8LoxP/LoxPCreERT2 or Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice, which were treated with tamoxifen at 6 weeks of age. The mean body weight of Spint2LoxP/+Prss8LoxP/LoxPCreERT2 mice did not decrease after tamoxifen treatment (Fig. 8a), suggesting that Prss8 is not essential for maintenance of the intestinal epithelium as reported previously24. Deletion of Prss8 gene did not rescue the lethal phenotype caused by postnatal deletion of Spint2. After tamoxifen treatment, the body weight loss of Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice was comparable to that of Spint2LoxP/LoxPPrss8LoxP/+CreERT2 littermate mice (Fig. 8a) and the intestinal tissues showed similar macroscopic changes (Fig. 8b). We next sought to determine whether Prss8 is required for Epcam cleavage in the presence of Hai-2 ablation in organoids prepared from the small intestines of Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice. In contrast to the observation in vivo, co-deletion of Prss8 suppressed Epcam cleavage, stabilized claudin-7 levels (Fig. 8c, d) and rescued destruction of crypt organoids caused by Hai-2 ablation (Fig. 8e).
Matriptase cleaved Epcam in Spint2 −/− organoids
It has been reported that Prss8 cannot directly cleave Epcam whereas matriptase can17. Thus, we asked whether matriptase was responsible for the enhanced cleavage of Epcam in Spint2-deleted intestinal organoids due to dysregulated Prss8-matriptase axis. Transfection of matriptase short hairpin RNA (shRNA) lentiviral vector reduced the matriptase mRNA level by 56%, which partly alleviated the Epcam cleavage in Spint2-deleted organoids (Fig. 9a, b). In accordance with this observation, matriptase-selective synthetic inhibitor ZFH7185-8 suppressed the Hai-2 loss-induced Epcam cleavage in a dose-dependent manner, accompanying stabilization of claudin-7 (Fig. 9c). In contrast, hepsin-selective inhibitor ZFH7185-3 did not show notable effects (Fig. 9c).
In this study, we demonstrated that acute ablation of the Hai-2 protein had a lethal effect on mice due to epithelial changes and intestinal dysfunction. Although increased exfoliation of epithelial cells and in turn active cellular proliferation occurred in the intestinal crypts, epithelial regeneration was abnormal such that the intestinal mucosa eventually showed severely disorganized architecture, atrophic villi, continuous exfoliation and tufted formations composed of enterocytes, as well as markedly elongated crypts. Mice carrying the Spint2 deletion all died within 6 days of initiating tamoxifen treatment.
Congenital SPINT2 mutations induce a syndromic form of CSD, and the intestinal epithelium of patients suffering from this rare autosomal-recessive disorder shows histological changes similar to those seen in CTE15,16. Conventional CTE is caused by a mutation in the EPCAM gene wherein abnormal EpCAM function destabilizes EpCAM-associated claudin-7, which eventually results in abnormally enhanced epithelial permeability15,21,22,25. Our organoid culture study revealed that Hai-2 loss accelerates Epcam protein cleavage, which was suppressed by the addition of protease inhibitors targeting trypsin-like serine proteases. Therefore, excess cleavage of Epcam by serine proteases could occur in the absence of Hai-2. Evidence indicates that HAI-2/Hai-2 regulates PRSS8/Prss8 in epithelial cells such as enterocytes, which influences matriptase localization and activation in the cells4,5,10,23. Given that EpCAM is a matriptase substrate in human enterocytes17, abnormal activity of the Prss8-matriptase axis could underpin the enhanced Epcam cleavage that occurred in the absence of Hai-2. Indeed, co-deletion of Prss8 and Spint2 in organoids relieved the Epcam cleavage in the absence of Hai-2, and consequently maintained the claudin-7 levels and rescued organoids from subsequent rupture. Moreover, silencing of matriptase in organoids or treatment of the organoids with matriptase-selective synthetic inhibitor alleviated the Hai-2 loss-induced Epcam cleavage. Therefore, Hai-2 tightly regulates Prss8-matriptase axis in the intestinal epithelial cells and dysregulation of this axis results in excess Epcam cleavage by matriptase and destabilization of the Epcam/claudin-7 complex.
Whereas co-deletion of Prss8 and Spint2 suppressed Epcam cleavage caused by Spint2 deletion in organoids, Spint2/Prss8 co-deletion could not rescue the lethal phenotype associated with Spint2 deletion in mice. This discrepancy may be consistent with recent observations in another CTE model: Spint2−/−Prss8R44Q/R44Q double mutant mice19. In the double mutant model, homozygous R44Q mutation of Prss8 gene resulted in the impaired activation of prostasin zymogen (i.e., zymogen-locked Prss8) and rescued embryonic lethality caused by the Spint2 deletion, and the intestinal development was normal in Spint2−/−Prss8R44Q/R44Q fetus at E18.519. However, after birth, Spint2−/−Prss8R44Q/R44Q mice showed severe growth retardation and died within a week with severe intestinal abnormalities reminiscence to CTE19. Thus, homozygous R44Q mutation in Prss8 rescued Spint2 deletion-induced CTE only during the fetal period. Environmental factors, such as intestinal microbial colonization and food intake, may underpin the conflicting observations between mice in vivo after birth and organoids ex vivo that might be equivalent to the fetal intestine. Nonetheless, these lines of evidence raise the question of whether Epcam cleavage is sufficient to induce the severe intestinal phenotype in vivo. In fact, the histological abnormalities observed in the colon mucosa of the Spint2-deletion mice in this study were more severe than those reported for Epcam mutant mice21,22. Moreover, our Spint2 knockout mice showed epithelial abnormalities in the gallbladder and extrahepatic bile duct, which were not reported in the Epcam knockout studies21,25. Therefore, the role of Hai-2 in epithelial cells may not be limited to stabilization of the Epcam/claudin-7 complex in the intestine, and Hai-2 may have additional, vital functions for epithelial cells in vivo. HAI-2/Hai-2 immunoreactivity has been observed primarily in the cytoplasm1,8,10, and it likely localizes to the endoplasmic reticulum (ER)9. HAI-2/Hai-2 may therefore have an important role in regulation of proteolysis in ER and intracellular secretory pathways, which might be required to maintain epithelial integrity in vivo. Further studies to identify proteins interacting with HAI-2/Hai-2 will be required.
Whether Hai-2 loss affects the activity of epithelial sodium channel (ENaC) also remains unclear. Prss8 and matriptase, which are both Hai-2 sensitive, are likely involved in ENaC activation3,24, and patients carrying SPINT2 gene mutations often experience sodium diarrhea. Although the severe effect of spontaneous Hai-2 ablation precluded analysis of ENaC function in our mouse model in vivo, ex vivo intestinal organoids from these mutant mice could provide a tool for future studies to explore the roles of Hai-2 and Prss8 in intestinal ENaC activation. Finally, the effect of Hai-2 loss on intestinal stem cells also awaits analysis. Given that the number of Lgr5-positive intestinal stem cells remained unchanged in Epcam-deleted mice21, intestinal stem cells may not be a primary target in the Spint2 deletion-induced phenotype. However, Paneth cells maintain the stem cell niche in intestinal crypts26, and the number of Paneth cells was decreased by Spint2 deletion. Therefore, the maintenance of stem cells may indeed be disturbed in the Spint2-deleted intestine.
The conditional Spint2 knockout mouse described in this report is the second mouse model of Hai-2 deficiency-induced CTE next to Spint2−/−Prss8R44Q/R44Q double mutant mouse recently reported by Szabo and Bugge19. Although both models show similar CTE morphology, there are a couple of differences in regard to histological findings. First, mucosal damage, inflammation and apoptotic epithelial cells were more evident in our model compared to the double mutant model. Second, Ki67-positive cells in the intestinal crypts increased significantly in our model, but not in the double mutant model. In addition, abnormalities observed in the extrahepatic biliary epithelium of our mutant mice were not reported in the double mutant mice19. These differences may be due to the method of Spint2 ablation: acute Spint2 ablation in postnatal period in our model versus genetically Spint2 null condition in the double mutant model. The strength of the Spint2-Prss8 double mutant model may be an early-onset intestinal failure after birth, which likely mimics the patients of congenital CTE19. However, Prss8 mutation is not reported in the CTE patients. The current conditional Spint2 knockout mouse model has wild-type Prss8 and has an advantage in this regard. Another important advantage of the current model is the availability of organoid culture. The intestinal organoids from Spint2LoxP/LoxPCreERT2 mice reproduces molecular changes induced by Hai-2 deficiency in vitro, providing an indispensable research tool for the study of CTE.
In conclusion, Hai-2 is a vital epithelial protease inhibitor that is needed to maintain the integrity of the intestine and extrahepatic biliary epithelia as well as to stabilize the Epcam/claudin-7 complex. Our Spint2-mutant mouse model together with the intestinal organoid culture from these mutant mice would provide a useful tool for detailed studies of HAI-2/Hai-2 function in epithelial cells and the screening of therapeutic compounds for patients carrying SPINT2 mutations. Successful inhibition of Hai-2 loss-induced Epcam cleavage by an exogenous serine protease inhibitor in an ex vivo organoid culture model could be important for developing treatments for intestinal failure induced by Spint2 mutations.
The following anti-mouse antibodies were used: anti-Hai-2 goat polyclonal antibody (pAb) (R & D Systems, Minneapolis, MN); anti-Epcam (ProteinTech., Rosemont, IL), anti-claudin-7 (Thermo Fisher Scientific, Waltham, MA), anti-mouse β-catenin (Sigma, St. Louis, MO), anti-cleaved caspase-3 (Cell Signaling, Boston, MA), and anti-lysozyme (AVIVA Systems Biology, San Diego, CA) rabbit pAbs; anti-Ki67 rabbit monoclonal antibody (mAb) (Abcam, Cambridge, UK); anti-E-cadherin goat pAb (R & D Systems); anti-claudin-2 and anti-ZO-1 rabbit pAbs (Thermo Fisher Scientific); anti-β-actin mouse mAb (Sigma) and anti-ssDNA rabbit pAb (Dako, Carpinteria, CA).
Generation of Spint2 conditional knockout mice
All of the animal work was performed under the approval of the University of Miyazaki Animal Research Committee, in accordance with international guidelines for biomedical research involving animals. The required portions of the mouse Spint2 gene were amplified by PCR from a mouse (C57BL/6) genomic bacterial artificial chromosome library and subcloned into a pBluescript II SK + phagemid vector (Agilent Technologies, Palo Alto, CA), which was used to construct a targeting vector. LoxP sites were inserted into exons 2 and 6 to delete all transcript variants of the Spint2 gene27,28 following activation of Cre recombinase. A neomycin resistance gene (neo) cassette for positive selection was inserted into intron 6 and was flanked by short flippase recognition target (FRT) sites. The targeting vector also contained a diphtheria toxin expression cassette for negative selection and had an MfeI site for screening by Southern blotting. The targeting vector was linearized with SacII and transfected into C57BL/6 strain ES cells by electroporation. Correctly targeted ES clones were selected using G418 (Sigma). Two independently targeted ES clones (ES16 and ES89) were obtained and microinjected into morulae of ICR mice. The resulting chimeras were mated with C57BL/6 mice. Germline transmission of the targeted allele was detected by progeny coat color and PCR. FLPeR mice29 were purchased from The Jackson Laboratory (Bar Harbor, ME) and the mutant mice were cross-mated for more than nine generations with C57BL/6 mice (Charles River Laboratories, Portage, MI). Then, Spint2LoxP/+/neo + mice were crossed to the B6-background FLPeR mice to remove the neo cassette. Heterozygous offspring (Spint2LoxP/+) were crossed to produce homozygous mutant offspring (Spint2LoxP/LoxP). Spint2LoxP/LoxP mice were further crossed with ROSA26-CreERT2 mice (The Jackson Laboratory) to generate ROSA26-CreERT2 mice with the floxed Spint2 gene (hereafter Spint2LoxP/LoxPCreERT2). To activate the CreERT2 recombinase, 6-week-old male mice were treated by intraperitoneal injection of 50 mg (135 μmol)/kg tamoxifen (Sigma) dissolved in corn oil for 3 consecutive days. Successful DNA rearrangement and loss of Spint2 mRNA were validated by genomic PCR and revere-transcription (RT)-PCR using DNA and total RNA, respectively, extracted from the tissues. The primers used for the validation described above are shown in Supplementary Fig. 1 and Supplementary Table 2. The site of each primer for genomic PCR is indicated in Fig. 1a. Unless otherwise indicated, data from the ES16 mouse line are presented.
To generate Spint2 and Prss8 double conditional knockout mice, Spint2LoxP/+CreERT2 mice were crossed with Prss8LoxP/+ mice30. Primer sequences for genotyping of the Prss8 mutant mice are shown in Supplementary Table 2.
For histological analysis, mice tissues were fixed in 4% formaldehyde in phosphate-buffered saline (PBS) and embedded in paraffin. Four-micrometer-thick sections were stained with hematoxylin and eosin (HE). Villus length and crypt depth were measured using Olympus cellSens imaging software (v1.15). To count the number of Paneth cells, ten randomly selected areas were photographed at 200× magnification from each mouse small intestine. Then, two independent investigators counted the number of Paneth cells per crypt. To count the number of goblet cells, large intestinal tissues were stained with alcian-blue, and ten randomly selected areas were photographed at 200× magnification from each mouse. Then, two independent investigators counted the number of goblet cells per crypt.
Immunohistochemical staining of mouse tissue sections
Mice were sacrificed at the indicated time point, autopsied and tissues were fixed with 4% formaldehyde in PBS. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue sections was performed as described previously31,32 except for Hai-2 and ssDNA. Briefly, tissue sections were processed for antigen retrieval by autoclaving for 5 min at 121 °C in 1 mM EDTA pH 8.0 for cleaved caspase-3 or in 10 mM citrate buffer pH 6.0 for other antibodies, followed by treatment with 3% H2O2 in PBS for 10 min. After blocking in 3% bovine serum albumin in PBS, the sections were incubated with primary antibodies for 16 h at 4 °C: anti-Ki-67 (1:100 dilution), anti-cleaved caspase-3 (1:300 dilution), anti-Lysozyme (1:50 dilution), anti-Epcam (1:250 dilution), anti-claudin-7 (1:100 dilution), and anti-β-catenin (1:2000 dilution). After washing with PBS, the sections were incubated with EnvisionTM labeled polymer reagents (DAKO) for 30 min at room temperature (RT). For anti-Hai-2 pAb (1:250 dilution), Ventana Discovery system (Ventana Medical System, Tucson, AZ) was used according to the manufacturer’s instructions. For immunostaining of ssDNA, deparaffinized tissue sections were incubated with PBS containing 0.2 mg/mL saponin (Nacalai Tesque, Kyoto, Japan) and 20 μg/mL Proteinase K (Nacalai Tesque) at RT for 20 min. After washing the slides in distilled water, sections were heated in preheated 50% formamide in distilled water at 56 °C for 20 min, followed by treatment with 3% hydrogen peroxide for 10 min and washing in PBS. After blocking in 3% non-fat dry milk for 20 min at 37 °C, the sections were incubated with anti-ssDNA (1:700 dilution) in 1% non-fat dry milk at RT for 30 min. The sections were then washed in PBS and incubated with Envision-labeled polymer reagent (DAKO) for 30 min at RT. The reaction was revealed with nickel, cobalt-3,3’-diaminobenzidine (Thermo Fisher Scientific) and counterstained with hematoxylin.
Intestinal permeability assay
To assess intestinal barrier function, an intestinal permeability assay was performed as previously described31. Briefly, 250 μg/g body weight fluorescein isothiocyanate (FITC)-dextran (4 kDa; Sigma) was administered to the mice by gavage 45 h after starting tamoxifen treatment. Three hours after administration of FITC-dextran, blood samples were obtained from the right ventricle, and EDTA-containing plasma samples were collected by centrifugation at 960 × g for 20 min at 4 °C. Plasma (75 μL) was diluted in 250 μL PBS, and fluorescence was quantified using a fluorometer (DTX800 Multimode Detector; Beckman Coulter, Fullerton, CA) with excitation and emission wavelengths of 485 and 535 nm, respectively. FITC-dextran concentrations were determined from standard curves generated by serial dilution of FITC-dextran.
Camostat mesilate administration
Camostat mesilate (Ono Pharmaceutical, Osaka, Japan) was administered to the mice through addition to the diet or by gavage, or intraperitoneal injection. For dietary administration, mice were given a diet containing 0.1% camostat mesilate three days before starting tamoxifen treatment until termination. For gavage or intraperitoneal injection, mice were treated with camostat mesilate solution (30 μg/μL water; 200 mg/kg) every 12 h beginning at the same time as tamoxifen treatment was initiated.
Matriptase-selective synthetic inhibitor
General procedure for the preparation of α-ketobenzothiazole (kbt) serine protease inhibitors for HGFA, matriptase or another TTSP namely hepsin has been reported previously33 and described in Supplementary Methods. Florescent kinetic enzyme inhibitor assays were performed to analyze the selectivity of the kbt inhibitors using either recombinant catalytic domains of HGFA34, matriptase (#3946-SEB, R&D Systems) or hepsin (#4776-SE, R&D Systems) in black 384 plates (Corning #3575, Corning, NY) (Supplementary Methods). Two kbt inhibitors, ZFH7185-8 and -3, were prepared (Supplemental Methods). ZFH7185-8 is Fmoc-Gly-Arg-kbt that is selective for matriptase (matriptase Ki, 0.13 nM; hepsin Ki, 831 nM), and ZFH7185-3 is Fmoc-Asn-Arg-kbt that is selective for hepsin (matriptase Ki, 106 nM; hepsin Ki, 1.7 nM) (Supplementary Methods).
Intestinal organoid culture
Isolation of intestinal crypts and organoid culture were performed as described previously35. Briefly, small intestine tissue isolated from 3- to 4-week-old male mice was washed with cold PBS and minced into 3 mm pieces. After washing again with cold PBS, the fragments were incubated for 30 min at 4 °C in PBS containing 2 mM EDTA, followed by centrifugation (400 × g, 3 min). Then, the fragments were suspended in cold PBS and passed through a 70-μm cell strainer (BD Biosciences, Bedford, MA). Isolated crypts were collected by centrifugation and further dissociated into single cells by Accumax (Innovative Cell Technologies, San Diego, CA) treatment for 5 min at 37 °C. For 3-D organoid culture, the dissociated single cells were resuspended in medium (Advanced DMEM/F12; Invitrogen, Tokyo, Japan) supplemented with 50 ng/mL EGF (Peprotech, Rocky Hill, NJ), 500 ng/mL R-Spondin1 (R&D systems), 100 ng/mL Noggin (Peprotech), 10 μM Y27632 (Wako, Osaka, Japan) and 1 μM Jagged-1 (AnaSpec, San Jose, CA), and seeded on Matrigel (60 μL/well; BD Biosciences) in 12-well plates, which were incubated overnight at 37 °C. After removing floating dead cells and medium, viable cells attached to the Matrigel were covered with 80 μL Matrigel and overlaid with complete culture media to resume 3-D culture. After the organoids formed, they were cultured with or without 1 μM 4-OHT (Sigma) in the presence or absence of aprotinin (Sigma) or camostat mesilate. To recover organoids from the Matrigel matrix and prepare sections, BD Cell Recovery Solution (BD Biosciences) was used according to the manufacturer’s instructions. Then the organoids were centrifuged (300 × g, 5 min) at 4 °C, formed into gels using iPGell (GenoStaff, Tokyo Japan) and fixed in 4% paraformaldehyde in PBS followed by embedding in paraffin. Sections (3 μm) were prepared and used for hematoxylin & eosin (HE) staining and immunostaining.
Analysis of junctional proteins in organoids
Organoids were extracted with RIPA buffer (Nacalai Tesque) and used for immunoblotting analysis. The membranes were incubated with antibodies against Epcam (1:1000 dilution), claudin-7 (1:1000 dilution), claudin-2 (1:1000 dilution), E-cadherin (1:1000 dilution), and β-actin (1:1000 dilution) at 4 °C overnight. To detect ZO-1, immunofluorescence staining was performed as described previously31. Briefly, organoids were fixed with 4% paraformaldehyde in PBS for 15 min, followed by blocking for 30 min with 5% normal goat serum (Dako) at RT. Then the organoids were incubated with anti-ZO-1 pAb (1:25 dilution) for 16 h at 4 °C. After washing, the cells were incubated for 30 min at RT with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen). Then, the organoids were counterstained with 4,’6-diamino-2-phenylindole (Sigma), and examined with an Axio Imager A2 (Carl Zeiss MicroImaging, Tokyo, Japan). To validate Epcam and claudin-7 mRNA expression, RT-PCR was performed using total RNA extracted from organoids. Primer sequences are shown in Supplementary Table 2. Full size immunoblots and gels for all experiments are shown in Supplementary Fig. 6.
Silencing of matriptase in organoids
For the silencing of matriptase (encoded by St14 gene) expression, shRNA against St14 was inserted into pLenti4/BLOCK-iT (Life Technologies Japan). Generation of the lentiviral particles was performed according to the manufacturer’s instructions. Lentiviral particles were infected as previously described35. The target sequence was 5′-GCGCTTCAAACTCTTCTATCT-3′. To confirm the efficiency of St14 gene knockdown, real-time RT-PCR was performed in a Thermal Cycler Dice Real Time System II (Takara Bio) using the SYBR Premix Ex Taq II (Takara Bio). The primer sequences are shown in Supplementary Table 2.
Statistical analysis was done using StatView 5.0 (SAS, Cary, NC, USA). Comparisons between two unpaired groups were done with the Mann–Whitney U-test, Student’s t-test or two-way repeated-measures analysis of variance (ANOVA). Significance was set at p < 0.05.
All data generated or analyzed during this study are included in this published article and its Supplementary Information files.
Kataoka, H., Kawaguchi, M., Fukushima, T. & Shimomura, T. Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer. Pathol. Int. 68, 145–158 (2018).
Kawaguchi, T. et al. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272, 27558–27564 (1997).
Antalis, T. M., Bugge, T. H. & Wu, Q. Membrane-anchored serine proteases in health and disease. Prog. Mol. Biol. Transl. Sci. 99, 1–50 (2011).
Friis, S. et al. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. J. Biol. Chem. 289, 22319–22332 (2014).
Lai, C. H. et al. Matriptase complexes and prostasin complexes with HAI-1 and HAI-2 in human milk: Significant proteolysis in lactation. PLoS ONE 11, e0152904 (2016).
Kawaguchi, M. et al. Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling. Am. J. Pathol. 185, 1610–1623 (2015).
Yamamoto, K. et al. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells. Oncotarget 9, 11691–11706 (2018).
Kataoka, H. et al. Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas. Cancer Lett. 148, 127–134 (2000).
Larsen, B. R. et al. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase. Exp. Cell Res. 319, 918–929 (2013).
Shiao, F. et al. Selective inhibition of prostasin in human enterocytes by the integral membrane Kunitz-type serine protease inhibitor HAI-2. PLoS ONE 12, e0170944 (2017).
Tanaka, H. et al. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol. Cell. Biol. 25, 5687–5698 (2005).
Szabo, R. et al. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development 136, 2653–2663 (2009).
Heinz-Erian, P. et al. Mutations in SPINT2 cause a syndromic form of congenital sodium diarrhea. Am. J. Hum. Genet. 84, 188–196 (2009).
Faller, N., Gautschi, I. & Schild, L. Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea. PLoS ONE 9, e94267 (2014).
Overeem, A. W., Posovszky, C., Rings, E. H., Giepmans, B. N. & van IJzendoorn, S. C. The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders. Dis. Model Mech. 9, 1–12 (2016).
Treetipsatit, J. & Hazard, F. K. Features of gastric and colonic mucosa in congenital enteropathies: a study in histology and immunohistochemistry. Am. J. Surg. Pathol. 38, 1697–1706 (2014).
Wu, C. J., Feng, X., Lu, M., Morimura, S. & Udey, M. C. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis. J. Clin. Invest. 127, 623–634 (2017).
Szabo, R. et al. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet. 8, e1002937 (2012).
Szabo, R. & Bugge, T. H. Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy. PLoS ONE 13, e0194660 (2018).
Szabo, R. et al. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J. Biol. Chem. 283, 29495–29504 (2008).
Mueller, J. L., McGeough, M. D., Peña, C. A. & Sivagnanam, M. Functional consequences of EpCam mutation in mice and men. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G278–G288 (2014).
Lei, Z. et al. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. Dev. Biol. 371, 136–145 (2012).
Buzza, M. S. et al. Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway. J. Biol. Chem. 288, 10328–10337 (2013).
Malsure, S. et al. Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance. J. Am. Soc. Nephrol. 25, 1453–1464 (2014).
Guerra, E. et al. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/beta-catenin. PLoS ONE 7, e49302 (2012).
Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).
Itoh, H., Kataoka, H., Hamasuna, R., Kitamura, N. & Koono, M. Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Biochem. Biophys. Res. Commun. 255, 740–748 (1999).
Kataoka, H. et al. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first kunitz domain potently inhibits the HGF activator. Biochem. Biophys. Res. Commun. 290, 1096–1100 (2002).
Farley, F. W., Soriano, P., Steffen, L. S. & Dymecki, S. M. Widespread recombinase expression using FLPeR (Flipper) mice. Genesis 28, 106–110 (2000).
Uchimura, K. et al. The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling. Nat. Commun. 5, 3428 (2014).
Kawaguchi, M. et al. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity. Am. J. Pathol. 179, 1815–1826 (2011).
Hoshiko, S. et al. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis. Cancer Res. 73, 2659–2670 (2013).
Han, Z. et al. α-Ketobenzothiazole serine protease inhibitors of aberrant HGF/c-MET and MSP/RON kinase pathway signaling in cancer. ChemMedChem 11, 585–599 (2016).
Han, Z. et al. Inhibitors of HGFA, matriptase, and hepsin serine proteases: A nonkinase strategy to block cell signaling in cancer. ACS Med. Chem. Lett. 5, 1219–1224 (2014).
Onuma, K. et al. Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc. Natl Acad. Sci. USA 110, 11127–11132 (2013).
We are grateful to Ms. J. Kurogi, Ms. Y. Torisu, Ms. A. Izumi, Ms A. Seto, and Mr. T. Kaieda for their skillful technical assistance and Dr. T. Shimomura for valuable discussion. This work was supported by Japan Society for the Promotion of Science KAKENHI 16H05175 (H.K.) and 15K08311 (M.K.); and by Grant for Clinical Research from Miyazaki University Hospital (H.K.).
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kawaguchi, M., Yamamoto, K., Takeda, N. et al. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. Commun Biol 2, 11 (2019). https://doi.org/10.1038/s42003-018-0255-8
This article is cited by
Human Genetics (2022)
Cancer and Metastasis Reviews (2020)